Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 96%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,682
Total Claims
$2.0M
Drug Cost
727
Beneficiaries
$2,734
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+88%
Opioid rate vs peers
4.9% vs 2.6% avg
+156%
Cost per patient vs peers
$2,734 vs $1,068 avg
+49%
Brand preference vs peers
13.4% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.9%
Opioid Rate
1,101
Opioid Claims
$16K
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,025 claims · $1.7M
Generic: 19,469 claims · $291K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 133 | $146K |
| Dapagliflozin Propanediol | 153 | $98K |
| Secukinumab | 12 | $93K |
| Tirzepatide | 76 | $92K |
| Dulaglutide | 88 | $85K |
| Apixaban | 134 | $74K |
| Empagliflozin | 115 | $74K |
| Dapaglifloz Propaned/Metformin | 91 | $73K |
| Insulin Glargine,hum.Rec.Anlog | 103 | $72K |
| Semaglutide | 60 | $68K |
| Insulin Glargine/Lixisenatide | 78 | $62K |
| Sitagliptin Phosphate | 117 | $55K |
| Rivaroxaban | 81 | $50K |
| Cariprazine Hcl | 32 | $47K |
| Linaclotide | 69 | $44K |
Prescribing Profile
Patient Profile
70
Avg Age
55%
Female
1.52
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About